Songwon to Start Up OPS Plant in Houston

Songwon Additive Technologies Americas has announced that production of OPS products (One Pack Systems) is to start at a new facility in Houston, USA in April this year. The Houston facility will have an initial capacity of 7.000 metric tons per year and follows Songwon´s investment in Additives Technology Greiz (ATG) in 2011 which was doubled in capacity in 2012 to 14.000 metric tons per year.

The Houston plant is part of Songwon's global OPS strategy being driven by a Joint Venture between Songwon Industrial Group, Pan Gulf Holding Company of Saudi Arabia and Polysys Industries of Abu Dhabi, for the manufacture and sale of Songnox OPS (One Pack Systems). OPS products combine a range of additives into one dust-free pellet form and offer a number significant advantages to molders and compounders of thermoplastic materials.

Songwon Additive Technologies and Polysys Industries have already announced that they will establish a new company Polysys Additive Technologies, which will build an OPS manufacturing plant in Kizad (Khalifa Industrial City of Abu Dhabi), Abu Dhabi to be on stream in the 1st quarter of 2014, also with a capacity of 7.000 metric tons per year.

 

Company

Logo:

Songwon International AG

Breitenstrasse 16
8501 Frauenfeld
Switzerland

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.